Status:
RECRUITING
Biobank for "Arrhythmia and Conduction Disorders: TowArd Pathophysiology Based Treatment"
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Conditions:
Arrythmia
Conduction Disorder
Eligibility:
All Genders
18+ years
Brief Summary
The 'ADAPT' Biobank is a collection of body material and data from patients with or at risk of cardiac arrhythmias who underwent or will undergo (non-) invasive treatment for this disease. Its main ob...
Detailed Description
The pathophysiological process of many cardiac arrhythmias is complex because of its multifactorial character. Despite extensive research that has already been performed in the field of electrophysiol...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients visiting the AMC outpatient clinic
- Patients included in an ongoing clinical trial linked to this biobank. Studies are listed under point "Groups and interventions" and include:
- MARK AF
- INDICO AF
- PREDICT AF
- WEIGHTLOSS AF
- MAD AF
- Patients included in future clinical trial linked to this biobank. Studies may be linked to this biobank that investigates prevalent or incident cardiac arrhythmias.
- Cardiac arrhtymias are defined as
- Supraventricular tachycardia, among which the most common are:
- Atrial Fibrillation (AF)
- Atrial Tachycardia (AT)
- Atrial Flutter (AFL)
- Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
- Atrioventricular Reentrant Tachycardia (AVRT)
- Ventricular tachycardia, among which the most common are:
- Ventricular Tachycardia (VT)
- Ventricular Flutter (VFL)
- Ventricular Fibrillation (VF)
- Bradycardia:
- Sinus Node Dysfunction
- AV Node Dysfunction
- Interventricular Conduction Disorder
- Arrhythmogenic cardiomyopathies, among which the most common are:
- Dilated Cardiomyopathy
- Restrictive Cardiomyopathy
- Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
- Exclusion criteria (shared for all studies):
- Age \< 18
- Unable or unwilling to comply with study procedures
- Pregnancy or of childbearing potential without adequate contraception
- NYHA class IV heart failure symptoms or left ventricular ejection fraction \<35%.
Exclusion
Key Trial Info
Start Date :
December 18 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2030
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04776642
Start Date
December 18 2014
End Date
January 1 2030
Last Update
January 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amsterdam University Medical Center location AMC
Amsterdam, Netherlands